levocarnitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule
- RxCUI
- 1091325
- RxNorm name
- levocarnitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule
- Display name
- levOCARNitine/Ubidecarenone/Vitamin E (Oral Pill)
- Full name
- levocarnitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule
- Term type
- SCD
- Status
- Active
- Strength
- 250-30-75 var units
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-07-15 00:15:51
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032011
- Active start
- 032011
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| vitamin E | 75 UNT / 1 EACH | vitamin E | d-alpha-tocopheryl acetate |
| ubidecarenone | 30 MG / 1 EACH | ubidecarenone | ubidecarenone |
| levocarnitine | 250 MG / 1 EACH | levocarnitine | levocarnitine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| vitamin E | 11256 |
| ubidecarenone | 21406 |
| levocarnitine | 42955 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | levOCARNitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule | NAMES |
| RxNorm Name | levocarnitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule | NAMES |
| RxNorm Synonym | alpha-tocopherol 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule | NAMES |
| TTY | SCD | ATTRIBUTES |
| RxCUI | 1091325 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A16AA | Amino acids and derivatives | ATC1-4 | levocarnitine | |
| ATC | C01EB | Other cardiac preparations | ATC1-4 | ubidecarenone | |
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | vitamin E | |
| FDASPL | D002331 | Carnitine | CHEM | has_chemical_structure | levocarnitine |
| FDASPL | N0000175903 | Carnitine Analog | EPC | has_epc | levocarnitine |
| MEDRT | D002331 | Carnitine | CHEM | has_ingredient | levocarnitine |
| MEDRT | D014451 | Ubiquinone | CHEM | has_ingredient | ubidecarenone |
| MEDRT | D014810 | Vitamin E | CHEM | has_ingredient | vitamin E |
| MEDRT | D000544 | Alzheimer Disease | DISEASE | may_prevent | vitamin E |
| MEDRT | D000544 | Alzheimer Disease | DISEASE | may_treat | vitamin E |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_prevent | vitamin E |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_treat | vitamin E |
| MEDRT | D000787 | Angina Pectoris | DISEASE | may_treat | ubidecarenone |
| MEDRT | D001997 | Bronchopulmonary Dysplasia | DISEASE | may_prevent | vitamin E |
| MEDRT | D003677 | Deficiency Diseases | DISEASE | may_treat | levocarnitine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | vitamin E |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levocarnitine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ubidecarenone |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | ubidecarenone |
| MEDRT | D004409 | Dyskinesia, Drug-Induced | DISEASE | may_treat | vitamin E |
| MEDRT | D004409 | Dyskinesia, Drug-Induced | DISEASE | may_prevent | vitamin E |
| MEDRT | D015673 | Fatigue Syndrome, Chronic | DISEASE | may_treat | ubidecarenone |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | ubidecarenone |
| MEDRT | D006816 | Huntington Disease | DISEASE | may_treat | ubidecarenone |
| MEDRT | D006949 | Hyperlipidemias | DISEASE | may_treat | ubidecarenone |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | ubidecarenone |
| MEDRT | D014811 | Vitamin E Deficiency | DISEASE | may_prevent | vitamin E |
| MEDRT | D014811 | Vitamin E Deficiency | DISEASE | may_treat | vitamin E |
| MEDRT | N0000000142 | Biological Macromolecular Activity | MOA | has_moa | levocarnitine |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | ubidecarenone |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | vitamin E |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | levocarnitine |
| MEDRT | N0000009934 | Decreased Vitamin Uptake and Modification | PE | has_pe | vitamin E |
| MEDRT | N0000009925 | Unknown Physiological Effect | PE | has_pe | ubidecarenone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 250 MG / 30 MG / 75 UNT |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SCD |
| CODES | RxCUI | 1091325 |
| NAMES | Prescribable Synonym | coenzyme Q10 30 MG / levOCARNitine 250 MG / vitamin E 75 UNT Oral Capsule |
| NAMES | RXNAV_STR | levOCARNitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule |
| NAMES | RxNorm Name | levocarnitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule |
| NAMES | RxNorm Synonym | alpha-tocopherol 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule |
| NAMES | Tallman Synonym | alpha-tocopherol 75 UNT / levOCARNitine 250 MG / ubidecarenone 30 MG Oral Capsule |
| NAMES | Tallman Synonym | levOCARNitine 250 MG / ubidecarenone 30 MG / vitamin E 75 UNT Oral Capsule |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |